NAP 226-90 CAS: 139306-10-8
MF: C10H15NO
MW: 165.23
A metabolite of Rivastigmine, which is a brain selective acetylcholinesterase inhibitor.

NAP 226-90 (CAS 139306-10-8)

NAP 226-90 | CAS 139306-10-8 is rated 5.0 out of 5 by 1.
  • y_2021, m_9, d_25, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.19
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_219332, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 112ms
  • REVIEWS, PRODUCT
loading
5
1
4
0
3
0
2
0
1
0
Application: NAP 226-90 is a metabolite of Rivastigmine, which is a brain selective acetylcholinesterase inhibitor
CAS Number: 139306-10-8
Purity: ≥99%
Molecular Weight: 165.23
Molecular Formula: C10H15NO
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).
loading

NAP 226-90 is an S-Enantiomer metabolite of Rivastigmine, which is a brain selective AChE (acetylcholinesterase) inhibitor.


References

Rosler, M., et al.: Br. Med. J., 318, 633 (1999), Jann, M., et al.: Clin. Pharmacokinet., 41, 719 (2002), Frankfort, S., et al.: Int. J. Clin. Pract., 60, 646 (2006),

Physical State :
Solid
Solubility :
Soluble in chloroform, DMSO, methanol, and water (slightly).
Storage :
Store at 4° C
Melting Point :
111-114° C
Boiling Point :
241.34° C at 760 mmHg (Predicted)
Density :
1.02 g/cm3 (Predicted)
Refractive Index :
n20D 1.54 (Predicted)
Optical Activity :
α20/D -57.14°, c = 0.85 in methanol; α20/D -55.5°±2.5°, c = 1 in methanol (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
MDL Number :
MFCD06656491
SMILES :
C[[email protected]](N(C)C)C1=CC=CC(O)=C1

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 120ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from NAP 226 NAP 226-90 is a metabolite of Rivastigmine that acts as a selective acetylcholinerase inhibitor in the brain; its use is cited in various publications. -SCBT Publication Review
Date published: 2015-07-12
  • y_2021, m_9, d_25, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.19
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_219332, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 13ms
  • REVIEWS, PRODUCT